Director, GI Oncology Lifecycle Management

Summary

Join Natera as a Director, GI Oncology Lifecycle Management for Hepatobiliary and Pancreatic Cancers, and play a pivotal role in shaping the strategic direction and execution for company success in these cancer types. You will own the lifecycle planning of Signatera, collaborate with cross-functional teams, lead a tumor-focused lifecycle team, and establish tumor-specific goals. Responsibilities include serving on clinical/medical and commercial subteams, maintaining expertise in Hepatobiliary and Pancreatic Cancers, driving market access efforts, developing KOL engagement strategies, shaping the value proposition for Natera’s oncology products, and regularly presenting to executive leadership. This remote position requires a Bachelor’s degree (advanced degree preferred), extensive experience in product marketing and market analytics within a pharmaceutical/biotech company, and a strong understanding of oncology molecular testing/biomarkers. The role involves approximately 25% travel.

Requirements

• Bachelor’s degree, Advanced degree preferred (MBA or PhD)
• >10 years experience in product marketing, market analytics at a pharmaceutical / biotech company
• Working knowledge of oncology molecular testing / biomarkers
• ~25% travel required (advisory boards, congresses, sales / marketing meetings, customer meetings
• Ability to lead without authority, influence and inspire individuals
• Proven strategic agility with an enterprise mindset and ability to operate with executive presence
• Ability to partner and collaborate across a broad range of internal and external partners
• Strong customer orientation and focus, particularly establishing thought leader relationships
• Proven ability to communicate the complex simply (biomarkers, multiple indications, etc.)
• Strong organizational / time management skills; manage and complete multiple projects

Responsibilities

• Own the lifecycle planning and success of Signatera in Hepatobiliary and Pancreatic Cancers , collaborating with cross-functional teams to develop and execute a strategic plan that drives usage, awareness, and advocacy across key stakeholders worldwide
• Lead a tumor-focused lifecycle team that is a cross-functional group accountable for progress on tumor goals and deploying resources to maximize outcomes
• Establish tumor-specific goals to be owned by the lifecycle team and across functions
• Serve as a critical member on clinical / medical teams, helping define and prioritize key opportunities while identifying and addressing evidence gaps
• Serve as a critical member on commercial subteams, helping to maximize Natera potential by escalating and addressing critical barriers that limit commercial adoption
• Maintain a deep expertise in the Hepatobiliary and Pancreatic Cancers space by integrating real-time customer insights, publications, data presentations, competitive and market intelligence
• Drive market access efforts, leading the development of reimbursement dossiers for Medicare/MolDx and commercial payers to secure coverage for non-covered indications
• Develop and execute KOL engagement strategies, collaborating with marketing and medical teams to gather insights, build relationships, and foster advocacy
• Shape the value proposition for Natera’s oncology products in collaboration with Medical Affairs and Commercial Marketing, leveraging clinical evidence and market dynamics
• Co-lead advisory boards and market research efforts in partnership with Medical Affairs
• Regularly present strategic plans and progress to executive leadership

Preferred Qualifications

• Prior experience/expertise in Hepatobiliary and/or Pancreatic Cancer indications strongly preferred
• Previous KOL management experience preferred

Benefits

• Comprehensive medical, dental, vision, life and disability plans for eligible employees and their dependents
• Free testing in addition to fertility care benefits
• Pregnancy and baby bonding leave
• 401k benefits
• Commuter benefits
• Generous employee referral program